CD36-positive CD8-positive T cells exhibit compromised immune functions, and a high level of infiltration of CD36-positive CD8-positive T cells predicts poor prognosis and inferior response to chemotherapy in patients with non-small cell lung cancer (Ao et al., 2023). This evidence concerns the gene CD36 and non-small cell lung carcinoma.